h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
MUi019-A
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
MUi019-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
MUi019-A (RRID:CVCL_QX58)
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
10th April 2017
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Mahidol University (MU)
External Databases
Cellosaurus
CVCL_QX58
Wikidata
Q54907066
General Information
Publications
Tangprasittipap A et al. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman. Stem cell research. 2017 Apr;20:91-93.
Linn AK et al. Establishment and Characterization of MUi027-A: A Novel Patient-Derived Cell Line of Polycystic Kidney Disease with
PKD1
Mutation. Journal of personalized medicine. 2022 May 9;12(5).
Linn AK et al. Unveiling the Antiviral Properties of Panduratin A through SARS-CoV-2 Infection Modeling in Cardiomyocytes. International journal of molecular sciences. 2024 Jan 24;25(3).
Thongsa-Ad U et al. Improving hematopoietic differentiation from human induced pluripotent stem cells by the modulation of Hippo signaling with a diarylheptanoid derivative. Stem cell research & therapy. 2024 Mar 3;15(1):60.
Janpipatkul K et al. Therapeutic delivery of recombinant glucocerebrosidase enzyme-containing extracellular vesicles to human cells from Gaucher disease patients. Orphanet journal of rare diseases. 2024 Oct 2;19(1):363.
Subclones
MUi019-A-1
MUi019-A-2
MUi019-A-3
MUi019-A-4
MUi019-A-5
MUi019-A-6
MUi019-A-7
MUi019-A-8
MUi019-A-9
MUi019-A-10
MUi019-A-11
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.